Cargando…
The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. The pathogenesis of CAD relates to the presence of atherosclerotic plaques in the coronary arteries, which are most frequently treated today by percutaneous coronary intervention. Small vessel disease treatment...
Autores principales: | Sanchez, Oscar D, Yahagi, Kazuyuki, Koppara, Tobias, Virmani, Renu, Joner, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284006/ https://www.ncbi.nlm.nih.gov/pubmed/25565907 http://dx.doi.org/10.2147/MDER.S50051 |
Ejemplares similares
-
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008) -
Long‐term (beyond 5 years) clinical impact of Xience everolimus‐eluting stent implantation
por: Matsuda, Hiroaki, et al.
Publicado: (2021) -
Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017) -
A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry – XIENCE V performance evaluation (THRIVE study)
por: Kiatchoosakun, Songsak, et al.
Publicado: (2017) -
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study
por: Franzone, Anna, et al.
Publicado: (2017)